InMed-logo-01

Filings

Form TypeForm DescriptionFiling DateReport DateView Report
8-KCurrent report11/25/202011/20/2020
8-KCurrent report11/18/202011/18/2020
SC 13GStatement of acquisition of beneficial ownership by individuals11/18/2020
8-KCurrent report11/16/202011/16/2020
424B4Prospectus [Rule 424(b)(4)]11/16/2020
8-KCurrent report11/13/202011/12/2020
EFFECTNotice of Effectiveness11/12/2020
3Initial statement of beneficial ownership of securities11/12/202011/12/2020
3Initial statement of beneficial ownership of securities11/12/202011/12/2020
3Initial statement of beneficial ownership of securities11/12/202011/12/2020
3Initial statement of beneficial ownership of securities11/12/202011/12/2020
3Initial statement of beneficial ownership of securities11/12/202011/12/2020
3Initial statement of beneficial ownership of securities11/12/202011/12/2020
3Initial statement of beneficial ownership of securities11/12/202011/12/2020
3Initial statement of beneficial ownership of securities11/12/202011/12/2020
3Initial statement of beneficial ownership of securities11/12/202011/12/2020
8-KCurrent report11/12/202011/12/2020
CORRESPCorrespondence11/10/2020
CORRESPCorrespondence11/10/2020
CORRESPCorrespondence11/10/2020
CERTForm - CERT11/6/2020
CORRESPCorrespondence11/5/2020
CORRESPCorrespondence11/5/2020
8-A12BRegistration of securities [Section 12(b)]11/5/2020
S-1/AGeneral form for registration of securities under the Securities Act of 1933 - amendment10/15/2020
UPLOADSEC-generated letter10/14/2020
CORRESPCorrespondence10/8/2020
S-1/AGeneral form for registration of securities under the Securities Act of 1933 - amendment10/8/2020
UPLOADSEC-generated letter9/23/2020
S-1/AGeneral form for registration of securities under the Securities Act of 1933 - amendment9/15/2020

Investor Alerts

Sign up for investor alerts!
Sign Up

Information Request

Send us a request for information
Learn More
InMed-logo-mono
#310 – 815 West Hastings St.
Vancouver, BC, Canada
V6C 1B4

Pharmaceutical

MANUFACTURING

Investor

CORPORATE

Learn

© Copyright 2023 InMed Pharmaceuticals Inc.

Subscribe

Sign up to receive emails from InMed Pharmaceuticals

"*" indicates required fields

Name*
Consent*